American Financial Group Inc Oragenics Inc Transaction History

American Financial Group Inc

  • $233 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.11 - $15.59 $1,489 - $211,088
13,540 New
13,540 $1,000

Others Institutions Holding OGEN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ORAGENICS INC

OGEN Quotes by TradingView
  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $36.1M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track American Financial Group Inc Portfolio

Follow American Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email